Table of Contents Table of Contents
Previous Page  FM9 860 Next Page
Information
Show Menu
Previous Page FM9 860 Next Page
Page Background

855

Re: Critical Analysis of Early Recurrence After Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT

N.J. Sathianathen, B.R. Konety

856

Re: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study

M. Brausi

857

Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

A. Bagrodia, Y. Lotan

859

What is a “Diagnostic Test Reference Range” Good for?

P. Habibzadeh, M. Yadollahie, F. Habibzadeh

e121

Re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9–10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766–73 http://dx.doi.org/10.1016/j.eururo.2017.01.018

T. Van den Broeck, R.J. Karnes, S. Joniau

e123

Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau’s Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9–10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766–73 http://dx.doi.org/10.1016/j.eururo.2017.01.017

A.U. Kishan, M.L. Steinberg, P.A. Kupelian, C.R. King

e125

Re: Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes. Adverse Disease Features in Gleason Score 3 4 “Favorable Intermediate-risk” Prostate Cancer: Implications for Active Surveillance. Eur Urol 2017;72:442–7 http://dx.doi.org/10.1016/j.eururo.2017.01.040

C. Du, H. Chen, C. Li

e126

Re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267–73 http://dx.doi.org/10.1016/j.eururo.2017.04.035

L. Mitrakas

e127

Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606–17 http://dx.doi.org/10.1016/j.eururo.2017.05.017

J.H. Kim, B.I. Chung

e129

Reply to Jae Heon Kim and Benjamin I. Chung’s Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606–17 http://dx.doi.org/10.1016/j.eururo.2017.05.010

M.C. Mir, I.H. Derweesh, R. Autorino

e131

Re: Julien Dagenais, Matthew J. Maurice, Pascal Mouracade, Onder Kara, Ercan Malkoc, Jihad J. Kaouk. Excisional Precision Matters: Understanding the Influence of Excisional Volume Loss on Renal Function After Partial Nephrectomy. Eur Urol 2017;72:168–70 http://dx.doi.org/10.1016/j.eururo.2017.05.019

J.H. Kim, B.I. Chung

e u r o p e a n u r o l o g y , vo l . 7 2 , n o . 5 , No v emb e r 2 0 1 7

Research Letter

Letters to the Editor

published online